"We are a full service GI group with 18 Doctors and 5 Physician Assistants. We are happy to take care of you and all of your GI needs. We can get you in to see a provider quickly."

During the past decade, Gastrointestinal and Liver Diseases Consultants PC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastrointestinal and Liver Diseases Consultants PC" #1 sponsor was "Shire" with 3 trials, followed by "Bausch Health Americas, Inc." with 1 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored, "Pharmos" with 1 trials sponsored and "Warner Chilcott" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastrointestinal and Liver Diseases Consultants PC" #1 collaborator was "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Gastrointestinal and Liver Diseases Consultants PC" are "Eosinophilic Esophagitis (EoE)" (3 trials), "Ulcerative Colitis" (3 trials), "Inflammatory Bowel Disease" (1 trials) and "Irritable Bowel Syndrome" (1 trials). Many other conditions were trialed in "Gastrointestinal and Liver Diseases Consultants PC" in a lesser frequency.

Most popular intervention types in "Gastrointestinal and Liver Diseases Consultants PC" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Oral Budesonide Suspension (OBS)" (2 trials), "Placebo" (2 trials), "Asacol 400 mg (mesalamine)" (1 trials), "Asacol 800 mg (mesalamine)" (1 trials) and "Asacol®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastrointestinal and Liver Diseases Consultants PC" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Gastrointestinal and Liver Diseases Consultants PC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Gastrointestinal and Liver Diseases Consultants PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gastrointestinal and Liver Diseases Consultants PC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".